Mesa Labs Inc (MLAB)

$100.79 -2.90 (-2.80%)
Market Cap 568.45M
Revenue (ttm) 240.98M
Net Income (ttm) -1.97M
EPS (ttm) N/A
PE Ratio 15.06
Forward PE 11.97
Profit Margin -0.82%
Debt to Equity Ratio 0.89
Volume 135,613
Avg Vol 125,764
Day's Range N/A - N/A
Shares Out 5.53M
Stochastic %K 59%
Beta 0.94
Analysts Sell
Price Target $104.50

Company Profile

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also pro...

Industry: Scientific & Technical Instruments
Sector: Technology
Phone: 303 987 8000
Address:
12100 West Sixth Avenue, Lakewood, United States
Estimize
Estimize May. 6 at 10:00 AM
Wall St is expecting 1.06 EPS for $MLAB Q1 [Reporting 07/30 BMO] http://www.estimize.com/intro/mlab?chart=historical&metric_name=eps&utm_co
0 · Reply
abeabdouh
abeabdouh Mar. 10 at 9:51 PM
$MLAB Mesa Laboratories (NASDAQ:MLAB) Director Acquires $99,940.00 in Stock
0 · Reply
BillionerOfKing
BillionerOfKing Mar. 10 at 3:23 PM
$MLAB Current Stock Price: $76.11
0 · Reply
Estimize
Estimize Mar. 4 at 11:01 AM
Wall St is expecting 1.54 EPS for $MLAB Q4 [Reporting 06/02 BMO] http://www.estimize.com/intro/mlab?chart=historical&metric_name=eps&utm_co
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 28 at 2:15 AM
$MLAB RSI: 57.44, MACD: 2.9990 Vol: 4.57, MA20: 90.98, MA50: 85.98 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
PenkeInvesting
PenkeInvesting Feb. 26 at 3:27 PM
Fundamental analysis of $MLAB (MESA LABORATORIES INC /CO/) based on financial data and reported results. #MLAB
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 25 at 3:28 PM
$MLAB
0 · Reply
IdaLarsen905
IdaLarsen905 Feb. 18 at 1:40 PM
$MLAB Diagnostic instruments firm with steady demand.
0 · Reply
DylanHarman593
DylanHarman593 Feb. 11 at 3:52 PM
$MLAB Mesa Labs; life sciences tools (sterilization monitoring); steady grower; tied to biopharma and healthcare capital spending.
0 · Reply
IN0V8
IN0V8 Feb. 4 at 7:45 PM
$MLAB Wells Fargo raises target price to $94 from $83
0 · Reply
Latest News on MLAB
Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year Results on May 27, 2026

May 5, 2026, 1:39 PM EDT - 8 days ago

Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year Results on May 27, 2026

Mesa Labs CEO Gary Owens to step down, Siddhartha Kadia to succeed

2026-03-09T20:36:49.000Z - 2 months ago

Mesa Labs CEO Gary Owens to step down, Siddhartha Kadia to succeed

Mesa Labs price target raised to $94 from $83 at Wells Fargo

2026-02-04T11:36:50.000Z - 3 months ago

Mesa Labs price target raised to $94 from $83 at Wells Fargo

Mesa Laboratories Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 7:30 PM EST - 4 months ago

Mesa Laboratories Transcript: 44th Annual J.P. Morgan Healthcare Conference

MESA LABS DECLARES QUARTERLY DIVIDEND

Jan 7, 2026, 5:00 PM EST - 4 months ago

MESA LABS DECLARES QUARTERLY DIVIDEND

Mesa Labs to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

Dec 18, 2025, 7:00 PM EST - 5 months ago

Mesa Labs to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

Mesa Labs price target raised to $83 from $75 at Wells Fargo

2025-12-15T11:31:12.000Z - 5 months ago

Mesa Labs price target raised to $83 from $75 at Wells Fargo

Mesa Laboratories Transcript: Jefferies London Healthcare Conference 2025

Nov 20, 2025, 7:00 AM EST - 6 months ago

Mesa Laboratories Transcript: Jefferies London Healthcare Conference 2025

Mesa Laboratories, Inc. to Participate in Upcoming Investor Conferences

Nov 12, 2025, 3:14 PM EST - 6 months ago

Mesa Laboratories, Inc. to Participate in Upcoming Investor Conferences

Mesa Labs price target raised to $115 from $110 at Jefferies

2025-11-07T19:35:22.000Z - 6 months ago

Mesa Labs price target raised to $115 from $110 at Jefferies

Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2025

Oct 3, 2025, 11:46 AM EDT - 7 months ago

Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2025

Mesa Laboratories Executes Previously-Announced Strategic Financing Plan

Aug 18, 2025, 2:01 PM EDT - 9 months ago

Mesa Laboratories Executes Previously-Announced Strategic Financing Plan

Mesa Labs upgraded to Equal Weight from Underweight at Wells Fargo

2025-08-07T11:00:30.000Z - 9 months ago

Mesa Labs upgraded to Equal Weight from Underweight at Wells Fargo

Mesa Labs Announces First Quarter Results

Aug 5, 2025, 8:00 AM EDT - 10 months ago

Mesa Labs Announces First Quarter Results

Mesa Laboratories, Inc. to Announce First Quarter Results on August 5, 2025

Jul 2, 2025, 3:20 PM EDT - 11 months ago

Mesa Laboratories, Inc. to Announce First Quarter Results on August 5, 2025

Mesa Labs price target lowered to $100 from $120 at Wells Fargo

2025-05-30T10:15:19.000Z - 1 year ago

Mesa Labs price target lowered to $100 from $120 at Wells Fargo

Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2025 Results

May 28, 2025, 8:00 AM EDT - 1 year ago

Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2025 Results

Mesa Labs Announces Third Quarter Results

Feb 4, 2025, 8:00 AM EST - 1 year ago

Mesa Labs Announces Third Quarter Results

Mesa Laboratories, Inc. to Announce Third Quarter Results on February 4, 2025

Jan 17, 2025, 1:15 PM EST - 1 year ago

Mesa Laboratories, Inc. to Announce Third Quarter Results on February 4, 2025

Mesa Labs price target lowered to $150 from $160 at Evercore ISI

2024-11-12T13:20:46.000Z - 1 year ago

Mesa Labs price target lowered to $150 from $160 at Evercore ISI

Mesa Labs Announces Second Quarter Results

Nov 7, 2024, 8:00 AM EST - 1 year ago

Mesa Labs Announces Second Quarter Results

Mesa Labs target raised, added to ‘Tactical Outperform’ list at Evercore ISI

2024-10-01T12:50:30.000Z - 1 year ago

Mesa Labs target raised, added to ‘Tactical Outperform’ list at Evercore ISI

Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2024 Results

Jun 5, 2024, 6:00 AM EDT - 2 years ago

Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2024 Results

Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results

May 31, 2024, 6:00 AM EDT - 2 years ago

Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results

Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024

May 22, 2024, 6:00 AM EDT - 2 years ago

Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024

MESA LABS ANNOUNCES AMENDMENT TO CREDIT FACILITY AND REPURCHASE OF SENIOR CONVERTIBLE NOTES

Apr 8, 2024, 8:00 AM EDT - 2 years ago

MESA LABS ANNOUNCES AMENDMENT TO CREDIT FACILITY AND REPURCHASE OF SENIOR CONVERTIBLE NOTES

Mesa Laboratories, Inc. to Announce Unaudited Fourth Quarter and Full Fiscal Year 2024 Results on May 24, 2024

Apr 1, 2024, 10:27 AM EDT - 2 years ago

Mesa Laboratories, Inc. to Announce Unaudited Fourth Quarter and Full Fiscal Year 2024 Results on May 24, 2024

Mesa Labs Releases Second Annual Responsible Business Program Brochure

Mar 15, 2024, 7:00 AM EDT - 2 years ago

Mesa Labs Releases Second Annual Responsible Business Program Brochure

Mesa Laboratories Appoints Mark Capone to its Board of Directors

Jan 8, 2024, 8:00 AM EST - 2 years ago

Mesa Laboratories Appoints Mark Capone to its Board of Directors

Mesa Labs Completes the Acquisition of GKE Science & Technology Co.

Jan 3, 2024, 8:00 AM EST - 2 years ago

Mesa Labs Completes the Acquisition of GKE Science & Technology Co.

Mesa Laboratories, Inc. to Announce Second Quarter Results on February 5, 2024

Dec 14, 2023, 10:47 AM EST - 2 years ago

Mesa Laboratories, Inc. to Announce Second Quarter Results on February 5, 2024

Mesa Labs Acquires GKE-GmbH Complementary Sterilization Indicators and Healthcare Channels to Mesa's SDC Platform

Oct 16, 2023, 3:00 AM EDT - 2 years ago

Mesa Labs Acquires GKE-GmbH Complementary Sterilization Indicators and Healthcare Channels to Mesa's SDC Platform

Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2023

Sep 13, 2023, 1:37 PM EDT - 2 years ago

Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2023

Mesa Laboratories, Inc. Announces Commitment to Disclose Scope 1 and 2 Greenhouse Gas Emissions

Aug 24, 2023, 4:02 PM EDT - 2 years ago

Mesa Laboratories, Inc. Announces Commitment to Disclose Scope 1 and 2 Greenhouse Gas Emissions

Mesa Laboratories, Inc. to Announce First Quarter Results on August 3, 2023

Jun 21, 2023, 11:50 AM EDT - 3 years ago

Mesa Laboratories, Inc. to Announce First Quarter Results on August 3, 2023

Mesa Labs Announces Unaudited Fourth Quarter and Full Fiscal Year 2023 Results

May 25, 2023, 8:00 AM EDT - 3 years ago

Mesa Labs Announces Unaudited Fourth Quarter and Full Fiscal Year 2023 Results

Mesa Labs Declares Quarterly Dividend

Jan 3, 2023, 5:00 PM EST - 3 years ago

Mesa Labs Declares Quarterly Dividend

Mesa Laboratories, Inc. to Announce Third Quarter Results on February 6, 2023

Dec 16, 2022, 11:59 AM EST - 3 years ago

Mesa Laboratories, Inc. to Announce Third Quarter Results on February 6, 2023

Mesa Labs Acquires Belyntic's Peptide Purification Business

Nov 17, 2022, 8:04 AM EST - 3 years ago

Mesa Labs Acquires Belyntic's Peptide Purification Business

Mesa Laboratories, Inc. Appoints Shiraz Ladiwala as Lead Independent Director

Nov 4, 2022, 3:49 PM EDT - 3 years ago

Mesa Laboratories, Inc. Appoints Shiraz Ladiwala as Lead Independent Director

Mesa Laboratories Appoints Tony Tripeny to its Board of Directors

Jun 27, 2022, 8:01 AM EDT - 4 years ago

Mesa Laboratories Appoints Tony Tripeny to its Board of Directors

Mesa Labs Reports Fourth Quarter and Full Fiscal Year Results

May 31, 2022, 8:00 AM EDT - 4 years ago

Mesa Labs Reports Fourth Quarter and Full Fiscal Year Results

Mesa Labs Closes Acquisition of Agena Bioscience

Oct 20, 2021, 12:05 PM EDT - 4 years ago

Mesa Labs Closes Acquisition of Agena Bioscience

Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc.

Sep 14, 2021, 7:00 AM EDT - 5 years ago

Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc.

Mesa Labs Reports Third Quarter Results for FY21

Feb 3, 2021, 8:00 AM EST - 5 years ago

Mesa Labs Reports Third Quarter Results for FY21

Mesa Labs Reports Second Quarter Results for FY21

Nov 5, 2020, 8:00 AM EST - 5 years ago

Mesa Labs Reports Second Quarter Results for FY21

Mesa Labs Reports First Quarter Results

Aug 6, 2020, 8:00 AM EDT - 6 years ago

Mesa Labs Reports First Quarter Results

Mesa Laboratories, Inc. Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock in Public Offering

Jun 16, 2020, 11:52 AM EDT - 6 years ago

Mesa Laboratories, Inc. Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock in Public Offering

Mesa Laboratories, Inc. Announces Upsizing and Pricing of Public Offering of Common Stock

Jun 9, 2020, 8:15 PM EDT - 6 years ago

Mesa Laboratories, Inc. Announces Upsizing and Pricing of Public Offering of Common Stock

Mesa Laboratories, Inc. Announces Proposed Public Offering of Common Stock

Jun 8, 2020, 4:01 PM EDT - 6 years ago

Mesa Laboratories, Inc. Announces Proposed Public Offering of Common Stock

Life Sciences Executive Shannon Hall Joins Mesa Labs Board of Directors

May 15, 2020, 8:00 AM EDT - 6 years ago

Life Sciences Executive Shannon Hall Joins Mesa Labs Board of Directors

MESA LABS DECLARES QUARTERLY DIVIDEND

Jan 9, 2020, 7:00 PM EST - 6 years ago

MESA LABS DECLARES QUARTERLY DIVIDEND

Mesa Labs Acquires Gyros Protein Technologies

Oct 31, 2019, 8:55 PM EDT - 7 years ago

Mesa Labs Acquires Gyros Protein Technologies

Estimize
Estimize May. 6 at 10:00 AM
Wall St is expecting 1.06 EPS for $MLAB Q1 [Reporting 07/30 BMO] http://www.estimize.com/intro/mlab?chart=historical&metric_name=eps&utm_co
0 · Reply
abeabdouh
abeabdouh Mar. 10 at 9:51 PM
$MLAB Mesa Laboratories (NASDAQ:MLAB) Director Acquires $99,940.00 in Stock
0 · Reply
BillionerOfKing
BillionerOfKing Mar. 10 at 3:23 PM
$MLAB Current Stock Price: $76.11
0 · Reply
Estimize
Estimize Mar. 4 at 11:01 AM
Wall St is expecting 1.54 EPS for $MLAB Q4 [Reporting 06/02 BMO] http://www.estimize.com/intro/mlab?chart=historical&metric_name=eps&utm_co
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 28 at 2:15 AM
$MLAB RSI: 57.44, MACD: 2.9990 Vol: 4.57, MA20: 90.98, MA50: 85.98 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
PenkeInvesting
PenkeInvesting Feb. 26 at 3:27 PM
Fundamental analysis of $MLAB (MESA LABORATORIES INC /CO/) based on financial data and reported results. #MLAB
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 25 at 3:28 PM
$MLAB
0 · Reply
IdaLarsen905
IdaLarsen905 Feb. 18 at 1:40 PM
$MLAB Diagnostic instruments firm with steady demand.
0 · Reply
DylanHarman593
DylanHarman593 Feb. 11 at 3:52 PM
$MLAB Mesa Labs; life sciences tools (sterilization monitoring); steady grower; tied to biopharma and healthcare capital spending.
0 · Reply
IN0V8
IN0V8 Feb. 4 at 7:45 PM
$MLAB Wells Fargo raises target price to $94 from $83
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 16 at 5:09 AM
$MLAB Current Stock Price: $87.66
0 · Reply
BearTamerTrading
BearTamerTrading Jan. 11 at 11:57 PM
On Watch for JPM Week: Part 2 $MLAB – Mesa Labs – will present on Jan 14, 2026. $AAPG – Ascentage Pharma Group International – announced presentation. $LFCR – Lifecore Biomedical – participating (1-on-1s and meetings).
0 · Reply
ProximityPro
ProximityPro Dec. 26 at 2:23 PM
$MLAB Market structure is quietly punishing unfocused strategies. Efficiency initiatives must translate into measurable productivity. Evidence of repeatability is likely to change market tone. Stronger outcomes appear only when priorities stay focused.
0 · Reply
JarvisFlow
JarvisFlow Dec. 15 at 6:27 PM
Wells Fargo has adjusted their stance on Mesa Laboratories ( $MLAB ), setting the rating to Equal-Weight with a target price of 75 → 83.
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 11 at 10:55 AM
$MLAB
0 · Reply
UsernameInUse
UsernameInUse Nov. 25 at 8:39 PM
$MLAB let's make few bucks here with 20k
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 14 at 6:44 PM
$MLAB
0 · Reply
Estimize
Estimize Nov. 11 at 9:00 PM
Wall St is expecting 1.40 EPS for $MLAB Q3 [Reporting 02/09 AMC] http://www.estimize.com/intro/mlab?chart=historical&metric_name=eps&utm_co
0 · Reply
IN0V8
IN0V8 Nov. 10 at 5:38 PM
$MLAB Jefferies raises target price to $115 from $110
0 · Reply